About Calico Biolabs
Calico Biolabs is a Healthcare company based in Pleasanton (United States) founded in 2012, and was acquired by Abcam in January 2019. Custom rabbit monoclonal antibodies are developed for research applications. Calico Biolabs offers products and services including Primary Antibodies, ELISA Kits, and Cell Lines. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is Abcam Limited. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Calico Biolabs was founded in 2012 in Pleasanton, United States, as a biotechnology firm specializing in antibody development. It operates as a part of Abcam, with a focus on custom rabbit monoclonal antibodies tailored for research and clinical laboratories, including ELISA assays. Products are designed specifically for immunohistochemical applications. Services provided encompass polyclonal and monoclonal antibody development, tissue sectioning, and process optimization for various laboratory needs.
- Headquarters Pleasanton, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website calicobio.com
- Social LinkedIn YouTube
- Acquired by Abcam (Jan 2019)
- Legal Name Abcam Limited
Products & Services of Calico Biolabs
Calico Biolabs offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Lines.
Highly cited antibodies for precise research applications.
Tools for consistent immunoassays in life science studies.
Validated gene-edited lines for advanced research purposes.
Apps and channels of Calico Biolabs
its YouTube channel Abcam has 2.43K subscribers and 30 videos.
Videos from Calico Biolabs
The most watched videos on Calico Biolabs's YouTube channel, Abcam (2.43K subscribers). Click a video to play it here.
More on Abcam.
Investors in Calico Biolabs
Calico Biolabs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abcam.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom |
Investor details for Calico Biolabs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Calico Biolabs
2 dated milestones of Calico Biolabs across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Calico Biolabs is founded.
- Exit Acquired by Abcam.
Competitors of Calico Biolabs
Calico Biolabs has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Calico Biolabs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Calico Biolabs (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Calico Biolabs
Complete news archive for Calico Biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Calico Biolabs
Calico Biolabs was founded in 2012.
Calico Biolabs is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Calico Biolabs was founded in 2012 in Pleasanton, United States, as a biotechnology firm specializing in antibody development. It operates as a part of Abcam, with a focus on custom rabbit monoclonal antibodies tailored for research and clinical laboratories, including ELISA assays. Products are designed specifically for immunohistochemical applications. Services provided encompass polyclonal and monoclonal antibody development, tissue sectioning, and process optimization for various laboratory needs.
Calico Biolabs's top competitors include GenScript, Epitomics and Vector Laboratories.
Calico Biolabs offers Primary Antibodies, ELISA Kits, and Cell Lines.
Calico Biolabs has 1 investor. Key investors include Abcam.
Calico Biolabs operates through Abcam Limited.
Yes. Calico Biolabs was acquired by Abcam in January 2019.